KMYY(SH:600518)2014-04-28 16:00Financial Performance - Operating revenue for the first quarter reached CNY 4,196,530,502.66, representing a growth of 26.31% year-on-year[9] - Net profit attributable to shareholders was CNY 591,056,379.08, an increase of 5.95% compared to the same period last year[9] - Basic earnings per share rose to CNY 0.269, up 5.91% from CNY 0.254 in the same period last year[9] - Operating profit was ¥798,726,754.59, up 20.1% from ¥665,106,310.74 year-over-year[31] - Net profit attributable to shareholders was ¥591,056,379.08, representing a 5.4% increase from ¥557,886,793.11 in the same period last year[31] Asset and Liability Changes - Total assets increased by 8.53% to CNY 24,149,464,575.94 compared to the end of the previous year[9] - The total liabilities of the company reached CNY 11.53 billion, compared to CNY 10.22 billion at the beginning of the year, which is an increase of approximately 12.9%[26] - Total assets increased to ¥22,705,406,816.11, up from ¥21,107,021,932.55 at the beginning of the year, marking a growth of 7.6%[29] - Total liabilities rose to ¥10,215,315,567.54, compared to ¥9,242,176,615.14 at the beginning of the year, indicating an increase of 10.5%[29] Cash Flow Analysis - Cash flow from operating activities decreased by 19.57% to CNY 477,403,932.04 compared to the previous year[9] - Net cash flow from operating activities decreased to ¥477,403,932.04, down 19.6% from ¥593,530,444.71 in the previous period[36] - Cash outflow for purchasing goods and services rose to ¥4,130,791,707.20, an increase of 61.8% compared to ¥2,556,865,706.28 last period[36] - Net cash flow from investment activities decreased by 493.99% to -¥768,775,001.46 primarily due to increased fixed and intangible asset purchases[17] - Total cash and cash equivalents decreased by ¥96,381,787.53 during the period, contrasting with an increase of ¥1,027,255,390.73 in the previous period[37] Shareholder Information - The total number of shareholders reached 100,879 as of the report date[12] - The largest shareholder, Kangmei Industrial Co., Ltd., holds 30.42% of the shares, totaling 668,874,274 shares[12] - The top ten shareholders include various entities, with significant stakes held by Kangmei Industrial and individual shareholders[12] Investment Activities - The company has invested ¥363,711,094.62 (36.37% of budget) in the second phase of the Huatuo International Traditional Chinese Medicine City project[18] - The company has budgeted ¥1,100,000,000.00 for the Gansu Dingxi Traditional Chinese Medicine Modern Warehousing and Logistics Center, with cumulative investment at ¥126,332,575.47 (11.48% of budget)[18] - The company has achieved a cumulative investment of ¥1,014,688,546.24 (101.47% of budget) in the Puning Traditional Chinese Medicine Professional Market project[19] Changes in Current Assets - Accounts receivable decreased by 38.85% to ¥101,517,279.89 due to reduced bill settlements during the reporting period[15] - Prepayments increased by 86.67% to ¥602,854,247.71 primarily due to increased advertising and goods payments[15] - Other current assets rose by 118.39% to ¥170,816,223.12 mainly from increased input VAT credits[15] - Inventory levels rose significantly to CNY 4.73 billion from CNY 3.79 billion, reflecting an increase of approximately 24.9%[25] Corporate Governance and Compliance - The report indicates that the financial statements for the first quarter have not been audited[6] - The company has committed to using raised funds strictly for agreed purposes, avoiding investments in real estate and financial-related businesses[24] - Kangmei Pharmaceutical has pledged to enhance the management of raised funds to ensure compliance with national policies and regulations[24]